URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Janet Casey

Concepts (246)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Otitis Media
23
2002
127
7.090
Why?
Anti-Bacterial Agents
26
2003
432
6.880
Why?
Pharyngitis
15
2000
92
5.460
Why?
Tonsillitis
13
2000
59
4.560
Why?
Streptococcus pyogenes
13
2003
102
4.540
Why?
Streptococcal Infections
14
2000
166
3.620
Why?
Penicillins
12
2000
94
3.310
Why?
Cephalosporins
9
2000
66
3.290
Why?
Pneumococcal Infections
9
2007
79
2.540
Why?
Streptococcus pneumoniae
13
2005
107
2.220
Why?
Haemophilus Infections
9
2009
74
1.560
Why?
Pneumococcal Vaccines
6
2005
64
1.560
Why?
Haemophilus influenzae
12
2005
131
1.490
Why?
Acute Disease
15
2002
570
1.490
Why?
Nasopharynx
6
2010
46
1.460
Why?
Infant
28
1997
2102
1.440
Why?
Whooping Cough
4
2003
41
1.430
Why?
Clinical Trials as Topic
7
2002
664
1.410
Why?
Child, Preschool
29
1996
2452
1.410
Why?
Child
25
1997
3897
1.170
Why?
Amoxicillin
6
2003
38
1.140
Why?
Diphtheria-Tetanus-acellular Pertussis Vaccines
3
2005
27
1.090
Why?
Randomized Controlled Trials as Topic
7
2003
400
1.040
Why?
Severity of Illness Index
6
2002
878
1.020
Why?
Otitis Media with Effusion
4
2003
35
0.990
Why?
Humans
56
1994
35000
0.980
Why?
Azithromycin
2
2003
19
0.940
Why?
Antibodies, Bacterial
7
2005
188
0.920
Why?
Drug Resistance, Multiple, Bacterial
4
2004
20
0.900
Why?
Physician's Practice Patterns
2
2003
223
0.880
Why?
Vaccines, Conjugate
4
2005
37
0.870
Why?
Treatment Outcome
13
1997
2487
0.820
Why?
Communicable Diseases, Emerging
2
2007
7
0.760
Why?
Bacterial Infections
3
2003
127
0.720
Why?
Prospective Studies
12
2003
1606
0.710
Why?
Moraxellaceae Infections
1
2010
3
0.710
Why?
Bacterial Outer Membrane Proteins
4
2009
61
0.690
Why?
Microbial Sensitivity Tests
7
2003
164
0.670
Why?
Adolescent
13
1997
4513
0.620
Why?
Diagnostic Errors
1
2008
87
0.610
Why?
Bacterial Proteins
5
2007
373
0.600
Why?
Treatment Failure
5
2004
125
0.590
Why?
Ambulatory Care
1
2008
140
0.580
Why?
Leukocyte Count
2
2003
152
0.580
Why?
Hemolysin Proteins
1
2007
14
0.580
Why?
Drug Prescriptions
2
2003
44
0.570
Why?
Bordetella pertussis
2
2003
24
0.570
Why?
Patient Selection
1
2008
197
0.560
Why?
Drug Hypersensitivity
1
2007
44
0.550
Why?
Respiratory Tract Infections
2
2003
150
0.550
Why?
Haemophilus Vaccines
3
2009
59
0.510
Why?
Pertussis Vaccine
1
2005
33
0.500
Why?
Adult
12
1997
10906
0.490
Why?
Pediatrics
1
2008
376
0.470
Why?
Polymerase Chain Reaction
4
1994
586
0.450
Why?
Drug Administration Schedule
7
2000
362
0.450
Why?
Anti-Infective Agents
2
2002
74
0.430
Why?
Recurrence
5
2003
656
0.430
Why?
Antigens, Bacterial
3
2011
96
0.420
Why?
Fever
1
2003
106
0.410
Why?
Moraxella (Branhamella) catarrhalis
4
2005
12
0.400
Why?
Cephalexin
3
2003
12
0.400
Why?
Serotyping
4
2005
65
0.390
Why?
United States
4
2006
2511
0.360
Why?
Male
23
1996
18870
0.350
Why?
Immunologic Memory
3
2006
132
0.350
Why?
Meningococcal Vaccines
4
2005
23
0.340
Why?
Female
21
1997
19061
0.330
Why?
Multilocus Sequence Typing
4
2010
11
0.330
Why?
Immunoglobulin G
5
2009
491
0.320
Why?
beta-Lactamases
3
2005
30
0.320
Why?
Tympanic Membrane
2
2008
19
0.310
Why?
Bacterial Typing Techniques
4
2005
21
0.270
Why?
Placebos
2
2003
177
0.260
Why?
Penicillin V
2
2003
26
0.260
Why?
Cefadroxil
2
2003
10
0.260
Why?
New York
4
2004
1191
0.250
Why?
Middle Ear Ventilation
2
2004
12
0.250
Why?
Evidence-Based Medicine
2
2007
197
0.240
Why?
Retrospective Studies
4
2007
2167
0.240
Why?
Penicillin Resistance
2
2000
29
0.240
Why?
Ear, Middle
2
2010
16
0.240
Why?
Cohort Studies
3
2003
912
0.230
Why?
Carrier State
2
2010
31
0.230
Why?
Serum
2
2010
12
0.230
Why?
Diagnosis, Differential
3
2003
855
0.210
Why?
Follow-Up Studies
4
2003
1757
0.210
Why?
Receptors, Cell Surface
1
1994
206
0.210
Why?
Time Factors
3
2003
3047
0.210
Why?
Coinfection
1
2012
5
0.200
Why?
Diphtheria Toxoid
3
2005
33
0.200
Why?
Antibiosis
1
2011
2
0.190
Why?
Sensitivity and Specificity
2
2010
866
0.180
Why?
ROC Curve
1
2011
119
0.180
Why?
Conserved Sequence
1
2011
102
0.180
Why?
Polysaccharides, Bacterial
3
2004
98
0.180
Why?
Bacteria
1
2010
80
0.170
Why?
Intercellular Adhesion Molecule-1
1
2010
124
0.170
Why?
Epidemiologic Research Design
1
2008
3
0.160
Why?
Predictive Value of Tests
1
2011
579
0.160
Why?
Process Assessment (Health Care)
1
2008
11
0.160
Why?
Otoscopy
1
2008
5
0.160
Why?
Drug Utilization
1
2008
44
0.160
Why?
Reproducibility of Results
2
2008
859
0.160
Why?
Milk, Human
1
2009
81
0.160
Why?
Bias (Epidemiology)
1
2008
41
0.160
Why?
Meningococcal Infections
2
2005
13
0.160
Why?
Infant, Newborn
3
2000
1772
0.160
Why?
Double-Blind Method
2
2005
985
0.150
Why?
CD4-Positive T-Lymphocytes
1
2011
299
0.150
Why?
Paracentesis
1
2008
8
0.150
Why?
Exudates and Transudates
1
2008
16
0.150
Why?
Molecular Epidemiology
1
2007
8
0.150
Why?
Outcome and Process Assessment (Health Care)
1
2008
74
0.150
Why?
Mannosyltransferases
1
2007
1
0.150
Why?
Congenital Disorders of Glycosylation
1
2007
1
0.150
Why?
B-Lymphocytes
1
2012
460
0.150
Why?
Siblings
1
2007
35
0.140
Why?
Cephaloridine
1
2007
2
0.140
Why?
Cefamandole
1
2007
3
0.140
Why?
Immunoglobulin E
1
2007
58
0.140
Why?
Cross Reactions
1
2007
110
0.140
Why?
Age Factors
2
2006
1060
0.140
Why?
Safety
1
2007
99
0.140
Why?
Breast Feeding
1
2009
180
0.130
Why?
Immunization, Secondary
1
2006
68
0.130
Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2006
59
0.130
Why?
Europe
1
2006
74
0.130
Why?
Acoustic Impedance Tests
1
2005
12
0.130
Why?
Phylogeny
3
2009
116
0.130
Why?
Macrolides
1
2005
16
0.130
Why?
Vaccines, Acellular
1
2005
4
0.130
Why?
Outcome Assessment (Health Care)
2
2003
275
0.120
Why?
Cost of Illness
1
2005
73
0.120
Why?
Neisseria meningitidis
1
2005
21
0.120
Why?
Odds Ratio
1
2006
301
0.120
Why?
Combined Modality Therapy
2
1997
459
0.120
Why?
Autoimmune Diseases of the Nervous System
1
2004
6
0.120
Why?
Gram-Positive Bacteria
1
2004
11
0.120
Why?
Behavioral Symptoms
1
2004
12
0.120
Why?
Health Care Costs
1
2005
99
0.120
Why?
Gram-Negative Bacteria
1
2004
21
0.120
Why?
Publication Bias
1
2004
8
0.120
Why?
Young Adult
1
2008
1013
0.120
Why?
Sex Distribution
1
2004
142
0.110
Why?
Drug Therapy, Combination
1
2005
375
0.110
Why?
Age Distribution
1
2004
201
0.110
Why?
RNA, Bacterial
1
2003
80
0.110
Why?
Antibodies, Monoclonal
1
2007
725
0.100
Why?
Practice Guidelines as Topic
1
2005
288
0.100
Why?
Risk Factors
2
2004
2172
0.100
Why?
Incidence
1
2004
644
0.100
Why?
Sequence Homology, Nucleic Acid
2
1994
144
0.100
Why?
Chronic Disease
1
2003
496
0.100
Why?
Cognition Disorders
1
2004
262
0.090
Why?
DNA Primers
2
1994
401
0.090
Why?
Dose-Response Relationship, Drug
1
2003
1085
0.090
Why?
DNA, Bacterial
2
2009
167
0.080
Why?
Enzyme-Linked Immunosorbent Assay
2
2009
459
0.080
Why?
Base Sequence
2
1994
1681
0.070
Why?
Molecular Sequence Data
2
1994
1993
0.070
Why?
Extracorporeal Membrane Oxygenation
1
1996
23
0.070
Why?
Anemia, Sickle Cell
1
1996
46
0.070
Why?
Respiratory Insufficiency
1
1996
56
0.070
Why?
Bone Marrow Transplantation
1
1997
189
0.060
Why?
Hematopoietic Stem Cell Transplantation
1
1997
124
0.060
Why?
Respiratory Distress Syndrome, Adult
1
1996
75
0.060
Why?
Neoplasm Recurrence, Local
1
1997
272
0.060
Why?
Erabutoxins
1
1994
1
0.060
Why?
Snakes
1
1994
3
0.060
Why?
Receptors, Urokinase Plasminogen Activator
1
1994
9
0.060
Why?
Genomic Library
1
1994
15
0.060
Why?
Glycosylphosphatidylinositols
1
1994
9
0.060
Why?
Multigene Family
1
1994
80
0.060
Why?
Urokinase-Type Plasminogen Activator
1
1994
64
0.060
Why?
Brain Neoplasms
1
1997
254
0.060
Why?
Exons
1
1994
165
0.060
Why?
Sequence Homology, Amino Acid
1
1994
287
0.060
Why?
HeLa Cells
1
1994
291
0.050
Why?
Antineoplastic Combined Chemotherapy Protocols
1
1997
409
0.050
Why?
Questionnaires
2
2004
942
0.050
Why?
Disease Susceptibility
1
2011
77
0.050
Why?
Chinchilla
1
2011
8
0.050
Why?
Drug Resistance, Bacterial
1
2011
41
0.050
Why?
Streptolysins
1
2011
12
0.050
Why?
Consensus
1
2011
15
0.050
Why?
Amino Acid Sequence
1
1994
1198
0.050
Why?
Interdisciplinary Communication
1
2011
41
0.050
Why?
Immunoglobulin D
1
2010
11
0.050
Why?
Oropharynx
1
2010
11
0.050
Why?
Mutation, Missense
1
2011
81
0.040
Why?
Epitopes
1
2011
200
0.040
Why?
Sequence Analysis, DNA
1
2011
161
0.040
Why?
Lipoproteins
1
2010
99
0.040
Why?
Infant Formula
1
2009
12
0.040
Why?
Antibody Formation
1
2010
176
0.040
Why?
Observer Variation
1
2009
137
0.040
Why?
Medical Records
1
2009
122
0.040
Why?
Patient Participation
1
2009
71
0.040
Why?
Genes, Bacterial
1
2009
163
0.040
Why?
Delayed-Action Preparations
1
2008
41
0.040
Why?
Single-Blind Method
1
2008
114
0.040
Why?
Pain Measurement
1
2009
241
0.040
Why?
Muscle Hypotonia
1
2007
6
0.040
Why?
Genetic Complementation Test
1
2007
56
0.040
Why?
Glycosylation
1
2007
61
0.040
Why?
Blindness
1
2007
33
0.040
Why?
Sex Factors
1
2009
561
0.040
Why?
Chi-Square Distribution
1
2008
320
0.040
Why?
Heterozygote
1
2007
120
0.040
Why?
Cross-Sectional Studies
1
2009
627
0.040
Why?
Antibody Affinity
1
2006
13
0.040
Why?
Blood Bactericidal Activity
1
2006
18
0.030
Why?
Diphtheria
1
2006
13
0.030
Why?
Tetanus
1
2006
17
0.030
Why?
DNA Mutational Analysis
1
2007
185
0.030
Why?
Immunoglobulin A
1
2006
88
0.030
Why?
DNA, Complementary
1
2007
261
0.030
Why?
Carrier Proteins
1
2010
410
0.030
Why?
Tetanus Toxoid
1
2006
40
0.030
Why?
Seizures
1
2007
123
0.030
Why?
Animals
2
1994
15647
0.030
Why?
Risk Assessment
1
2009
808
0.030
Why?
Central Nervous System Viral Diseases
1
2004
4
0.030
Why?
Phenotype
1
2007
727
0.030
Why?
Child Welfare
1
2004
53
0.030
Why?
Mice
1
1994
5900
0.030
Why?
Psychomotor Performance
1
2004
157
0.030
Why?
Administration, Oral
1
2003
302
0.030
Why?
Multivariate Analysis
1
2004
487
0.030
Why?
Neuropsychological Tests
1
2004
355
0.030
Why?
Mutation
1
2007
1183
0.020
Why?
Streptococcus
1
2000
79
0.020
Why?
Pinealoma
1
1997
4
0.020
Why?
Busulfan
1
1997
13
0.020
Why?
Melphalan
1
1997
27
0.020
Why?
Ependymoma
1
1997
8
0.020
Why?
Medulloblastoma
1
1997
17
0.020
Why?
Fibrosarcoma
1
1997
32
0.020
Why?
Transplantation, Autologous
1
1997
136
0.020
Why?
Cyclophosphamide
1
1997
169
0.020
Why?
Glioblastoma
1
1997
55
0.020
Why?
Radiography, Thoracic
1
1996
56
0.020
Why?
Syndrome
1
1996
203
0.020
Why?
African Continental Ancestry Group
1
1996
116
0.020
Why?
Oxygen Consumption
1
1996
193
0.020
Why?

Visualizations


Casey's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department